JADPRO | Volume 15, Number 2 (Mar 2024)

Editorial

Burnout in Advanced Practitioners and the Benefit of Protected Time

Today, I learned an interesting fact. There is a diagnosis code to classify what many of us currently struggle with: burnout. The International Statistical Classification of Diseases and Related Health Problems (ICD-10) has a classificat...

March 25, 2024

Research and Scholarship

Burnout and Resiliency Among Advanced Practice Providers in Oncology Care

Abigail Baugh,(1) MPAS, PA-C, Victoria Reiser,(1) AG-ACDNP, BMTCN, OCN®, Jian Zhao,(2) PhD, RN, MS, Sara Jo Klein,(2) MS, BSN, RN, and Margaret Quinn Rosenzweig,(2) PhD, FNP-BC, AOCNP®, FAAN

Background: Occupational exhaustion, or burnout, is characterized with three components: emotional exhaustion, depersonalization, and sense of decreased personal accomplishment. Advanced practice providers (APPs) in oncology care are at ...

March 25, 2024

Research and Scholarship

A Comprehensive Bone Marrow Aspirate and Biopsy Educational Program Utilizing Task Trainers

Background: Advanced practice providers (APPs) who care for patients with hematologic malignancies perform bone marrow aspiration and biopsies (BMBXs). Invasive bedside procedures are often taught through the observational training metho...

March 25, 2024

Review Article

Risk Factors for Immune Checkpoint Inhibitor–Related Myocarditis: An Integrative Review

Purpose: The purpose of this integrative literature review was to determine factors that increase the risk of immune checkpoint inhibitor (ICI)–related myocarditis in the cancer patient population. Methods: A literature review was conduc...

March 25, 2024

Grand Rounds

Intravenous Cetirizine Premedication to Mitigate Infusion-Related Reactions

Infusion-related reactions (IRRs) are a recognized concern for chemotherapy, biologic agents, and newer immunotherapies. Antihistamines are frequently recommended to prevent or manage these reactions. For over 60 years, diphenhydramine h...

March 27, 2024

Practice Matters

The Ethics of Genetic Testing for Inherited Cancer-Predisposing Genes

Once an individual has been identified as a carrier of an inherited cancer-predisposing gene or pathogenic germline variant (PGV), there are measures that have been proven to prevent and diagnose the associated cancers at an earlier, mor...

March 27, 2024